Hitachi

NEW YORK (GenomeWeb) – OmniSeq said today that Hitachi High-Technologies has taken an option to exclusively license its OmniSeq Comprehensive and Immune Report Card tests for clinical distribution in Japan after participating in the company's Series B funding round. OmniSeq — a subsidiary of ...

Photonics Handbook ESPOO, Finland, April 10, 2018 — VTT Technical Research Centre of Finland has signed a memorandum of understanding with Hitachi High-Technologies Corp. to collaborate on the development and commercialization of silicon photonics and optical data transfer components. The partnership will ...

TOKYO -- Hitachi has received a roughly 10 billion yen ($93.8 million) order for an advanced cancer therapy system from a Taiwan hospital, its first overseas sale of heavy-ion therapy. The Japanese conglomerate announced Wednesday that it won the order from Taipei Veterans General Hospital. Delivery ...

March 30 (Renewables Now) - Hitachi Europe Ltd, Mitsubishi Motors (TYO:7211) and Engie (EPA:ENGI) have launched a project in the Netherlands to study the potential for electric vehicles (EVs) to act as energy storage for office buildings. As part of the project, a vehicle-to-everything (V2X) charger has been linked to ...

Hitachi Europe Ltd., Mitsubishi Motors and ENGIE are partnered in a project to explore the potential for electric vehicles to act as a means of energy storage for an office building. For this demonstration, the consortium linked Hitachi's vehicle-to-everything (V2X) charger to ENGIE's office building in Zaandam ...

Through a new collaboration, Mitsubishi Tanabe Pharma will apply Hitachi's digital technology such as artificial intelligence to make clinical trials more efficient. The partnership focuses on cutting the time spent on searching and collecting information from medical papers and ClinicalTrials.gov in the ...

AMEC unveiled the Primo nanova inductively coupled plasma (ICP) etcher for high-volume front-end production of memory and logic integrated circuits (ICs). Key features include a symmetric chamber configuration that enables high-pumping speed, as well as a low-capacitive coupling coil design and a ...

Hitachi, Ltd. (TSE:6501, “Hitachi”) is to invest in a fund managed by Geodesic Capital, a venture capital firm active in Silicon Valley. Hitachi will invest as a limited partner in Geodesic Capital Fund I-S, a supplemental fund (of a value up to US$165m) of the firm's first fund which was established in 2015.

Hitachi thus plans to entrust output of low-priced products to electronics manufacturing services providers, choosing EMS companies in China and India. This will make it more cost-competitive in the region. High-performance appliances for Asian markets outside Japan will still be made at home to boost the ...

Looking to reduce its dependence on the conventional in-car infotainment systems, Clarion has been collaborating with Hitachi to develop autonomous-parking technology that uses a smartphone. The subsidiary started supplying electronic control units for autonomous parking this fiscal year for Nissan ...

The parent apparently wants to put its automotive business on track for further growth, hiring a former executive of Swiss technology company ABB to lead automotive equipment subsidiary Hitachi Automotive Systems. Hitachi turned Clarion into a subsidiary in 2006 by raising its stake from slightly more ...

Mitsubishi Tanabe Pharma Corporation (TSE: 4508) and Hitachi (TSE: 6501) are aiming to improve the efficiency of clinical trials for the development of new drugs using digital technology such as artificial intelligence (AI). They hope to reduce the time and cost of studies, while increasing the probability of ...

The companies undertake a wide range of operations to make clinical trials more efficient overall, using Hitachi's advanced digital technology such as AI, aiming to shorten the period for development of new drugs and reduce development cost, while improving the probability of successful development.

Hitachi Chemical has entered into agreements with Daiichi Sankyo and SanBio Group to manufacture regenerative medicines developed by the respective companies. On March 19, 2018, Hitachi signed an agreement with Daiichi Sankyo to conduct clinical manufacturing of that company's regenerative ...

Hitachi Power Tools, Braselton, Ga.: Hiro Yumoto, president and CEO, Hitachi Koki USA, has been named chief strategy officer for Hitachi Koki Co. in Japan. This new position was created to oversee corporate strategy, branding strategy, product management strategy, and advertising and public relations strategy. Yumoto ...

The transition will start from September 2018 with the launch of MultiVolt, while the majority of products will changeover after December 2018. Products will retain current brand identity: same color, same model numbers, same warranties and the same battery interchangeability. They will be made by the ...

Daiichi Sankyo Co. Ltd. announced it will team up with Hitachi Chemical Co. Ltd. for the manufacturing of Daiichi's clinical candidates for regenerative medicine. Hitachi Chemical plans to start manufacturing Daiichi's unnamed clinical product at its new process development/contracting facility in Yokohama ...

Hiro Yumoto, President & CEO of Hitachi Koki USA, Ltd has been appointed Chief Strategy Officer for Hitachi Koki Co, Ltd in Japan. This appointment is a new position created to oversee corporate strategy, branding strategy, product management strategy and advertising & public relations strategy. Yumoto ...